Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

25 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

23 Sep 2016 Wright Reports 65 $75.00

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Analysis Review

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Analysis Review Summary Glenmark Pharmaceuticals Ltd. (Glenmark) manufac...

16 Sep 2016 GlobalData 61 $300.00

Company Snapshot - Glenmark Pharmaceuticals Limited

Two Directors at Glenmark Pharmaceuticals Limited bought 10,610 shares at 0.000INR. The significance rating of the trade was ...

07 Sep 2016 Directors Deals Ltd. 1 $12.00

MOSL: GLENMARK PHARMA 1QFY17 (Neutral)-Operational performance in line-PAT beat due to forex gains

GLENMARK PHARMA 1QFY17: Operational performance in line; PAT beat due to forex gains (GNP IN, Mkt Cap USD3.4b, CMP INR846, T...

16 Aug 2016 Motilal Oswal Securities Ltd. 10 $104.00

Spark Capital: 1QFY17 outlook review of Glenmark Pharmaceuticals (Rating: SELL, TP: Rs. 807)

1QFY17 outlook review of Glenmark Pharmaceuticals (Rating: SELL, TP: Rs. 807) How does our one year outlook change? We...

16 Aug 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Glenmark Pharmaceuticals_Q1FY17 Result Update

Glenmark Pharmaceuticals (GNP IN) reported in-line with expectation numbers. Sales growth was aided by good growth in almost ...

16 Aug 2016 IndiaNivesh Securities Pvt Ltd 7 $69.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - August 13, 2016

Glenmark Pharma (Bloomberg: GNP IN; HOLD; TP – Rs 900; 6% upside from CMP of Rs 846) Glenmark’s (GNP) Q1 EBITDA growth (up 5%...

16 Aug 2016 Axis Capital Limited 7 $69.00

GLEN.NS - Event Transcript of Glenmark Pharmaceuticals Ltd conference call, Aug. 12, 2016 / 6:00AM ET

Edited Event Transcript of GLEN.NS conference call, Aug. 12, 2016 / 6:00AM ET Boston, Aug 12, 2016 (Thomson StreetEvent...

12 Aug 2016 Thomson Reuters StreetEvents 27 $75.00